Objective eliciting doses of peanut-allergic adults and children can be combined for risk assessment purposes

Clin Exp Allergy. 2015 Jul;45(7):1237-44. doi: 10.1111/cea.12558.

Abstract

Background: To improve food labelling strategies, information regarding eliciting doses (EDs) and the effect of patient characteristics on these EDs is necessary.

Objective: To establish EDs for objective and subjective symptoms and analyse the effect of sensitization levels and other patient characteristics on threshold distribution curves (TDCs).

Methods: Threshold data from 100 adults and 262 children with a positive food challenge were analysed with interval-censoring survival analysis (ICSA) and fitted to a TDC from which EDs could be extracted. Possible influencing factors were analysed as covariates by ICSA. A hazard ratio (HR) was calculated in case of a significant effect.

Results: TDCs for both objective and subjective symptoms were significantly different between adults and children (P < 0.001). Objective ED05 values, however, were comparable (2.86 mg peanut protein in adults and 6.38 mg in children). Higher levels of sIgE to Ara h 2 and peanut extract were associated with a larger proportion of patient groups reacting to a dose increase with objective symptoms (adults and children) or subjective symptoms (adults, in children a trend). Age had a similar effect in children (HR 1.05 for objective symptoms and 1.09 for subjective symptoms). Gender had no effect on TDCs.

Conclusion and clinical relevance: Subjective and objective TDCs were different between adults and children, but objective ED05 values were comparable, meaning that threshold data from children and adults can be combined for elaboration of reference doses for risk assessment. Higher sIgE levels to Ara h 2 and peanut extract were associated with a larger proportion of both patient groups to react to a certain dose increase.

Keywords: eliciting dose; food challenge; peanut allergy; risk assessment; threshold distribution curve.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Allergens / administration & dosage
  • Allergens / immunology*
  • Antigens, Plant / administration & dosage
  • Antigens, Plant / immunology*
  • Arachis / adverse effects*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Male
  • Peanut Hypersensitivity / diagnosis*
  • Peanut Hypersensitivity / epidemiology
  • Peanut Hypersensitivity / immunology*
  • Risk Assessment*
  • Risk Factors
  • Young Adult

Substances

  • Allergens
  • Antigens, Plant